Brief: Minovia Therapeutics And Launch One Acquisition Announce JV To Create Mitochondrial Therapy Company
25/06/2025 13:41
June 25 (Reuters) - Launch One Acquisition Corp LPAA.O: MINOVIA THERAPEUTICS LTD. AND LAUNCH ONE ACQUISITION CORP. ANNOUNCE PROPOSED BUSINESS COMBINATION TO CREATE NASDAQ-LISTED MITOCHONDRIAL THERAPY COMPANY IN $1 TRILLION+ MITOCHONDRIAL AND LONGEVITY MARKETS MINOVIA THERAPEUTICS - COMBINED ENTITY TO OPERATE AS MITO US ONE LTD. ON NASDAQ MINOVIA THERAPEUTICS - UNDER DEAL, CO ASSIGNED PRE-MONEY EQUITY VALUATION OF $180 MILLION Source text: ID:nGNX3rB1sZ Further company coverage: LPAA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Launch One Acquisition
See all newsBrief: Minovia Therapeutics Receives FDA Fast Track Designation For Mnv-201 In Myelodysplastic Syndrome
Brief: Minovia Therapeutics Receives FDA Fast Track Designation For MNV-201 In Myelodysplastic Syndrome
Brief: Minovia Therapeutics And Launch One Acquisition Announce JV To Create Mitochondrial Therapy Company
Brief: Launch One Acquisition Completes $230.0 Million Initial Public Offering